Last reviewed · How we verify
NCT01035723
Effect of Functional Genetic Polymorphisms on Brain Morphology and Function
trial in Drug Abuse in 221 participants. Completed in 25 February 2013.
Quick facts
| Lead sponsor | National Institute on Drug Abuse (NIDA) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 221 |
| Start date | 13 September 2005 |
| Estimated completion | 25 February 2013 |
| Sites | 1 location across United States |
Conditions studied
- Drug Abuse — all drugs for Drug Abuse →
Sponsor
National Institute on Drug Abuse (NIDA)
Who can join
Adults 18 to 50, any sex, with Drug Abuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: \- New research on genetics and the human genome has helped to identify certain genes that affect specific parts of the brain, including the parts that may be involved in drug use and dependency. Researchers are interested in studying both genetic information and brain activity to better understand variations in brain function among individuals. Objectives: \- To study brain activity in conjunction with specific genetic information provided by healthy volunteers including smokers, non-smokers, people with drug dependence, and those who do not have any dependence on any substance. Eligibility: \- Healthy volunteers between 18 and 50 years of age. Design: * This is an 8 10 hour study which may be completed in 1, 2, or 3 visits. * Participants will complete questionnaires about emotional and psychological responses to different situations, including stressful situations. * Participants will have a training session in a mock (fake) scanner to practice tasks to be completed in the real scanner. * Participants will have the following two types of magnetic resonance imaging (MRI) scans in one scan session of the brain: * A structural MRI scan to provide basic information about each participant's brain. * A functional MRI scanning session, in which participants will perform a memory task to provide information about brain activity. * Participants will provide blood samples for research and testing....
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01035723
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Drug Abuse
Currently open trials in the same condition.
- NCT06134882 — OUD Smartphone Services · NA · active not recruiting
- NCT05918601 — Peer-led Personalized Support Program · NA · recruiting
- NCT05818384 — Wakaya: Rising Up for Choctaw Youth Health · NA · recruiting
- NCT05877742 — AA on Drug Abusers by Nursing Students · NA · recruiting
- NCT04822987 — Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs) · active not recruiting
Other National Institute on Drug Abuse (NIDA) trials
Trials by the same sponsor.
- NCT07468552 — Trial of Tirzepatide for the Treatment of Cannabis Use Disorder · Phase 2 · not yet recruiting
- NCT06808932 — VK4-116 Phase I Study With Food-Effect · Phase 1 · not yet recruiting
- NCT06676059 — SMART-r: Substance Monitoring and Active Relapse Tracking Repository · recruiting
- NCT06577454 — Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Sub · NA · suspended
- NCT06868914 — Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01035723 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute on Drug Abuse (NIDA)
- Last refreshed: 16 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01035723.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing